Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HAMID REZA MIRSHAHIDI

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1659307015
CMS profile
637935
Location
LOMA LINDA, CA

General Payments · PY2018–2024

$44,241.07

  • Reported across 88 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,041.69

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $1,057.50 1
Food and Beverage $610.97 13
Travel and Lodging $307.23 1
Education $65.99 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $24,527.29 28
PY2019 $7,605.81 9
PY2020 $3,895.84 5
PY2021 $189.09 5
PY2022 $3,886.29 9
PY2023 $2,095.06 16
PY2024 $2,041.69 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $65.99 01/30/2024 Education Undisputed 01/23/2026 1139382890 CMS
AstraZeneca Pharmaceuticals LP $95.08 09/08/2024 Food and Beverage Undisputed 01/23/2026 1105675743 CMS
Daiichi Sankyo Inc. $1,057.50 07/10/2024 Consulting Fee Undisputed 01/23/2026 1089457832 CMS
E.R. Squibb & Sons, L.L.C. $14.16 02/02/2024 Food and Beverage Undisputed 01/23/2026 1101788577 CMS
Gilead Sciences, Inc. $42.32 09/08/2024 Food and Beverage Undisputed 01/23/2026 1133833292 CMS
Merck Sharp & Dohme LLC $18.77 01/18/2024 Food and Beverage Undisputed 01/23/2026 1141625467 CMS
Merck Sharp & Dohme LLC $29.26 04/18/2024 Food and Beverage Undisputed 01/23/2026 1141625461 CMS
Merck Sharp & Dohme LLC $24.57 10/03/2024 Food and Beverage Undisputed 01/23/2026 1141846869 CMS
Merck Sharp & Dohme LLC $23.95 12/05/2024 Food and Beverage Undisputed 01/23/2026 1141625459 CMS
Novartis Pharmaceuticals Corporation $24.59 02/09/2024 Food and Beverage Undisputed 01/23/2026 1087106246 CMS
Partner Therapeutics, Inc. $150.00 12/12/2024 Food and Beverage Undisputed 01/23/2026 1141328818 CMS
Partner Therapeutics, Inc. $307.23 12/12/2024 Travel and Lodging Undisputed 01/23/2026 1141328986 CMS
Partner Therapeutics, Inc. $48.29 12/13/2024 Food and Beverage Undisputed 01/23/2026 1141328848 CMS
Partner Therapeutics, Inc. $49.99 12/13/2024 Food and Beverage Undisputed 01/23/2026 1141328878 CMS
Partner Therapeutics, Inc. $24.99 12/13/2024 Food and Beverage Undisputed 01/23/2026 1141328908 CMS
Partner Therapeutics, Inc. $65.00 12/13/2024 Food and Beverage Undisputed 01/23/2026 1141328938 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.